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Technical Approach to Generate Polyclonal
Antibodies Against Bacterially Expressed GSTPYK-C: Evaluation of Cross-Reaction and
Recognition in Some Mammalian and Yeast Cell
Lysates
Abstract: Pyk-2 is a protein tyrosine kinase,
highly expressed in human hippocampus,
dentate gyrus and olfactory bulb. In this
study, polyclonal antibodies against the Cterminal of pyk-2, starting from Pro-759,
were generated by injecting rabbits with the
bacterially expressed GST fusion construct,
generated by cloning the C-terminal domain
of pyk-2 into pGEX-3X vector and affinity
purification to increase the specificity of
recognition. Anti-pyk-C was shown to
recognize a 123 kD band in Western Blots of
293 cells transfected with pyk-2, as well as
PC-12, COS and 3T3 cells and not to crossreact with FAK transfected Sf-21 lysates, in

Introduction
Pyk-2 (protein tyrosine kinase-2) is a protein tyrosine
kinase expressed in human brain, embryonic lung, liver,
bone marrow cells and megacaryocytes (1-3). The tissue
distribution by Northern blot studies of human brain
sections and in situ hybridization analysis in rat brain
showed that the highest levels of pyk-2 mRNA are seen in
the hippocampus, dentate gyrus and olfactory bulb (1).
The so-named RAFTK (related adhesion focal tyrosine
kinase) (2) and CAK-β (cell adhesion kinase β) (3), named
after their identification by separate groups are identical
with pyk-2 in their amino acid sequences. Thus pyk-2 is a
1009 amino acid protein with a calculated molecular mass
of 123 kD. The homology comparison of the amino acid
sequence of the catalytic domain of pyk-2 with the four
most related protein tyrosine kinases FAK (focal adhesion
kinase), Fer, Her and Abl demonstrated 61, 43, 40 and
41 % sequence identity (1). The molecular physiologic
studies done on cell cultures indicate that pyk-2 is
phosphorylated on stimulation by nicotinic acetylcholine
receptors, in response to calcium influx, by protein kinase

spite of high sequence homology with FAK.
This is an early study to develop quantitative
immunochemical diagnostic assays, to
determine the importance of pyk-2 in human
physiology through clinical laboratory
investigations. The use of bacterial
expression systems in preference to other
choices for antigen generation against native
mammalian proteins are discussed, in context
of the description of ‘functional epitope’.
Key Words: pyk-2, Central Nervous System,
Molecular Cloning, Gene Fusion, Bacterial
Proteins, Antibody Formation, Antibody
Specificity, Immunochemistry, Immunoblotting.

C dependent and independent mechanisms, as well as on
stimulation of G-protein coupled receptors such as
bradykinin through elevation of cytosolic calcium,
mediated by inositol 1, 4, 5 P activation. In addition, pyk2 phosphorylates and activates Kv1.2 potassium channels
and also recruits shc/grb-2/sos complexes activating MAP
kinase functions.
The knowledge acquired is through in vitro
experiments and there is no information about the
possible importance of pyk-2 as a diagnostic and
theurapetic target for human health.
The use of immunochemical assays for description of
clinical states is widely available. However, it is well
known that the epitope selection at the antibody
generation step as well as the use of antigens generated
in procaryotic expression systems may lead to variations
in the antigen antibody recognition reaction. The purpose
of this study was to generate antibodies to detect pyk-2,
to be used in mammalian immunochemical assays to
evaluate the clinical usefulness of the molecule for future
clinical laboratory studies.

This study was conducted on a graduate fellowship grant from the Turkish Higher Educational Council, at Cornell University Biochemistry, Molecular
and Cell Biology Department, Ithaca, NY, USA
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Materials and Methods
Construction of vectors carrying GST-pyk-C fusion
protein genes

Sepharose 4B chromatography resin by 10 mM reduced
glutathione in 50 mM Tris. HCl (pH 8.0)
Animal Immunizations

The sequence at the C-terminal of pyk-2 starting from
Pro-759 was selected for antibody production with
respect to abundance of surface residues, higher
hydrophilicity, high antigenicity and least homology with
FAK as well as the existence of convenient restriction sites
for in frame cloning into pGEX-3X (Pharmacia, NJ).
Amino acid sequence analysis of pyk-2 was done by a
sequence analysis software (CGC Scientific, Inc, MO)
(Figure 1). DNA was excised from pBS-pyk2 cloning
vector (Strategene, CA) by Hpa I and Eco RI digestions
and inserted into the SmaI-EcoRI digested PGEX-3X in
frame. The resulting plasmid named pGEX-3X-pyk C was
used to generate the fusion protein GST-pyk-C (Figure 2).
Transformation of E. coli DH5α by pGEX-3X-pyk-C was
done as described previously (6) and selection for
ampicillin resistance was carried out.

The immunization schedules and procedures were
performed in the Animal Handling Facility of the
Veterinary Medical School at Cornell University, Ithaca,
NY as described elsewhere (5) in compliance with ethical
regulations. Injections were given to two New Zealand
white rabbits once every four weeks with a concentration
of 200mg in 0.5 ml PBS. The rabbits received Freund’s
complete adjuvant antigen for the primary vaccination
and Freund’s incomplete adjuvant antigen for boosting.
Preimmune sera was collected from both rabbits as well
as immune sera one week following every immunization.
Generation of immune response was followed by Western
blots at each step of immunization. A total of 3
immunizations and one booster injection were given
before sacrificing the rabbits.

Expression and Purification of GST-pyk-C fusion
protein

The antisera obtained from the test bleeds were
tested for pyk-2 recognition by Western Blotting, the
lysates obtained from Sf-21(ATCC, MD) transfected with
pyk-2 constructs as well as 293 (ATCC, MD) cell extracts
transfected with pCMV-LIC-pyk2 (Invitrogen, CA).
Western Blotting was performed at 1:3000 dilution of
the serum using the Amersham electrochemiluminescence
system as previously described (6). The anti-serum was
stored at -70˚C in 0.2 % NaN3. On proof of recognition,
the rabbits were sacrificed.

GST-pyk-C fusion proteins were expressed in E. coli
and purified according to the directions supplied by the
manufacturer (Pharmacia, NJ). Briefly, bacteria with
recombinant plasmids were grown to A600 of 0.6-0.8
with vigorous agitation at 37˚C in LB medium with 50 µg
/ml ampicillin. After the assessment of the expected
cellular density, fusion protein expression was induced by
adding 10 µl/ml of 100 mM IPTG. After incubation for 3
more hours at 37˚C equal volumes of cells were collected
by centrifugation, pellets were resuspended in 300 µl ice
cold phosphate buffered saline (PBS) containing a cocktail
of protease inhibitors (aprotinin, 2 µg/ml; leupeptin, 20
µg/ml; antipain 25 µg/ml) and lysed by sonication 3x30
seconds. Bacterial cell lysis was followed by increased
color formation on dye-binding protein assays (Bio-Rad
laboratories, CA). Soluble supernatant was obtained by
centrifugation at 16,000g for 15 minutes and GST-pykC
fusion proteins were purified from the soluble fraction by
chromatography on Gluthathione-Sepharose 4B
(Pharmacia, NJ). 20 µl of 50% Gluthathione Sepharose
4B was added to each supernatant, mixed gently for 5
minutes, centrifuged and washed 4 times with 50 µl PBS.
The GST beads with bound fusion protein were boiled
with SDS loading dye, run at 70 Volts constant voltage at
10% SDS-PAGE and stained with Commasssia Blue for
detection of clones expressing GST-pyk-C.
The selected colony named E. coli DH5α pGEX 3X
pyk-C was regrown in abundance and GST-pyk-C protein
was purified by and eluted from the Glutathione-

356

Western Blotting for test of recognition

Affinity Purification of the Specific IgG recognizing
GST-pyk-C
300 ml bacterial culture containing pGEX-3X-pyk-C
was induced with 0.1 M IPTG, centrifuged, and lysed by
sonication in 50 µl/ml PBS+Triton X-100. 1.8 ml of
lysate was loaded on a 10% SDS gel and run with 70 V.
A thin slice of gel was stained with Commasssia Blue to
identify the position of the fusion protein as well as for
quantitation. The remainder was transferred to
nitrocellulose paper and incubated with 5% milk to block
the paper followed by TBST wash (7). Meanwhile rabbit
anti-GST pyk-C serum was incubated with 250 µl/ml
50% slurry of GST beads equilibrated with PBS for 1
hour to eliminate anti-GST antibodies. After
centrifugation the supernatant was used to incubate the
blocked blot for 6 hours at 4˚C. The specific antibodies
bound were eluted by washing the paper with 200 µl of
100 mM glycine (pH 2.8) followed by immediate
neutralization (1M Tris.Cl pH 8.0). For quantitation SDSPage loaded and Commassia stained eluate were
compared with albumin standards.

A. AYYILDIZ

Detection of Specificity

Results

The improvement in specificity was detected by
Western Blotting of the total cell lysates obtained from
COS, 3T3, PC-12 cells and 293 cells transfected with
pyk-2, Sf-21, Sf21 transfected with FAK and Sf-21
tranfected with FAK N. COS, 3T3 and PC-12 cell lysates
were prepared in 1% Nonidet P-40 lysis buffer (20mM
Tris pH8.0, 137 mM NaCl, 1% Nonidet P-40, 10%
glycerol,
1
mM
Na3
VO4,
1mM
phenylmethylsulfonylfloride, 0.2 trypsin inhibitory
unit/ml aprotinin and 20 mg/ ml leupeptin) as previously
described (6). Sf21 lysates were a kindly donated by Jun
Lin Guan.

Figure 1 demonstrates the strategy to decide on the
peptide sequence to be used for highest antigenicity. The
sequence between the amino acids 750-880 shows an
array of highly hydrophilic sequences with considerably
high surface probability and antigenicity. In addition to
these, the existence of an Hpa I restriction site prior to
Pro-759 makes in frame cloning into the Sma I blunt end
convenient. Assuming the average molecular weight
(MW) of an amino acid was approximately 110 Daltons,
the calculated MW for GST-pyk-C would be 53.5 kD of
which 26 kD is acquired from GST. Figure 3 shows
several bacterial expression patterns. Lane 1 is E. coli
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Figure 3.

Commassia stained SDS-PAGE demonstrating expression of
GST-pyk-C.
Colonies from E.coli transformants were grown and
induced with IPTG for expression of bacterial GST fusion
proteins. Cells were lysed by sonication and resuspended in
PBS. The supernatants were incubated with 50%
gluthathione sepharose 4B except lane 2 and loaded on
SDS-PAGE after boiling in SDS-PAGE loading dye for 3
minutes.

in PC-12 cells which endogenously express pyk-2 as well
as in 293 cells transfected with pyk-2 in mammalian
expression vector. There is observable recognition in COS
and 3T3 cells as well, though not as prominent as in lane
3 and 4. It is notable that the highest band intensity is
observed in the 293 pyk-2 transfected lysates. On the
other hand, there is no observable FAK recognition on
transfected Sf-21 cells in comparison with native SF-21
extracts which implies lack of cross-reactivity. Lane 7
shows the Sf-21 lysates transfected with N-terminal FAK
where cross-reaction of a low molecular weight band is
detectable in Figure 5a . Figure 5b blotted with purified
anti-serum shows a decrease in non-specific recognition in
comparison with Figure 5a blotted with native antiserum.

Lane 1. pGEX-3X transformant Lane 2. Untransfected but
induced E.coli DH5a.
Lane 3 and 4. Molecular weight markers. Lane 5. pGEX3X-pyk-C transformant
Lane 6. PGEX-FAK-C transformant.

transfected with pGEX-3X, induced with IPTG and finally
adsorbed on GST-beads. The prominent band
corresponds to the 26kD GST whereas lane 6 is pGEXFAK-C induced and purified in the same fashion. These
experiments were conducted to observe the efficiency of
induction. Lane 2 is native E. coli DH5a induced with
IPTG. Lane 3 and 4 are the molecular weight markers. In
lane 5, it is observed that cloning and expression has led
to successful synthesis of the GST-pyk-C fusion protein.
However, it is interesting to observe the variety of bands
indicating the changes in the metabolism of bacteria
implied by changes in protein expression patterns due to
the expression of the exogeneous transfected proteins
(15). After elution
of the GST-pyk-C specific
immunoglobulins by affinity purification, the eluate was
evaluated by Commasssia stained SDS-PAGE in
comparison with known quantities of albumin. Figure 4
shows evidence of IgG eluted on affinity purification. By
visual estimation, it is calculated that the concentration of
purified antibody is 0.04mg/ml. IgG is a 150 kD protein
with 2 heavy and 2 light chains. The upper band
corresponds to the double overlapping heavy chains and
the faint lower band in lane 4 corresponds to the light
chains. For detection of specificity and possible crossreaction with FAK, the experiment in Figure 5 was
conducted. A band of approximately 123 kD is observed
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Figure 4. Quantitation of anti-GST-pyk-C antibodies purified by
immunoadsoprtion of rabbit GST-pyk-C antiserum in
comparison to albumin.
The pool containing the specific antibodies after affinity
purification was run on SDS-PAGE ( (lane 4; 15 ml, lane 5;
5 ml, lane 6; 1 ml ) and compared to albumin (lane 7; 6
mg, lane 8; 2 mg, lane 9; 0.4 mg ). Lane 1; molecular
weight markers.

Figure 5a.

Western Blot with GST-pyk-C antiserum. Cell lysates were
Western Blotted with 1:3000 dilution of rabbit GST-pyk-C
antiserum. Arrow indicates the 123 kD band for pyk-2.
Lane 1. COS. Lane 2. 3T3. Lane 3. PC12. Lane 4. 293
transfected with pyk-2.
Lane 5. Sf21. Lane 6. Sf21 transfected with FAK. Lane 7.
Sf21 transfected with N FAK.

A. AYYILDIZ

to be possible however, there must be a complementarity
between the additional surface area of the antibody and
the antigen.

Figure 5b.

Western Blot with affinity purified anti-GST-pyk-C antibody.
Western Blot of the same lysates with 1:500 dilution of
affinity purified anti-GST-pyk-C antibody.

Discussion
It is well known that the most important
determinants of antigen-antibody binding specificity are
the physical characteristics of the two interacting
molecular surfaces, such as their shape, complementarity,
electrostatic charge, and polarity (7). The most
conspicious properties common to all humoral antigenic
epitopes are their convex shape and the presence of large,
polar, and charged amino acid side chains. A typical
preparation of immune sera consists of a
microheterogeneous mixture of molecules of the same
antigenic specificity but different amino acid sequence in
the antigen binding parts of the molecule. Through
solution binding studies, there is evidence that antibodies
are capable of recognizing the smallest structural
variations in otherwise cross-reacting ligands (8).
Antiprotein antibodies sometimes specifically recognize
short peptides; such antibodies can be elicited by sythetic
peptide antigens. The majority of antigenic sites in
proteins, however, seem to consist of amino acids that are
not contiguous in the amino acid sequence (composite or
discontinious epitopes).
A concept of ‘functional (energetic)’ epitope originally
formulated in computational analysis of X-ray
chrystallographic structures, has found support in
extensive alanine-scanning mutagenesis experiments of
antigen-antibody complexes (9). Accordingly, only a small
part of the total antibody and antigen contact surface
(some 30-40% thereof, or three to four amino acid
residues) appears to contribute actively to binding, often
via hydrogen bonds and buried salt links. This smaller
contact area, namely functional, or energetic epitope,
belongs to the most protruding parts of the antigenic
surface, where side chains such as Arg, Glu, Gln, Lys and
Pro are particularly abundant. For the complex formation

The rationale for making antibodies to recognize pyk2 was to develop immunochemical methods to investigate
the function and significance of pyk-2 in human
physiology through clinical laboratory investigations. The
approach taken for making pyk-2 anti-serum was
injecting rabbits with GST-fusion proteins constructed by
cloning the C-terminal of pyk-2 into pGEX-3X expression
vector in frame. Protein engineering taking advantage of
computer aided structural design based on available X-ray
crystallographic coordinates has become a widely used
tool for antigen engineering by gene cloning technologies
(11, 12). It has been postulated that in attempts to
generate antibodies against bacterial compounds using
synthetic peptides, the response against the protein in its
native conformation may be low (13). In order to
maximise specific recognition, through increasing the
microheterogeneity and preferring to recognize the
folded native structure (10) of pyk-2, cloning a longer
sequence rather than using synthetic peptides approach
was taken in this study. In some bacterial expression
vectors, it is possible to engineer secretable proteins.
Insolublity of bacterial proteins forming ‘inclusion bodies’
is another difficulty for bacterial protein expression
systems. In this study we were able to obtain pyk-C
antigen as a soluble cytoplasmic protein. C-terminal
fragment of pyk-2 starting from pro-759 was selected
for making recombinant antigen mainly for the
convenience of in frame cloning, in addition to
hydrophilicity designating solubility. Soluble cytoplasmic
protein purified was used for the injections. However, the
peptide sequence was evaluated for antigenicity and
surface probabity by a commercial protein sequence
analysis tool, as well. FAK being a protein with high
amino acid sequence homology to pyk-2 was tested for
cross-reactivity and the antibody was found to be non
cross-reactive with FAK. The non-specific recognition
bands which were abundant before affinity purification
lessened after the purification step.
One concern often voiced in the case of recombinant
antigens is the potential structural therefore functional
differences between recombinant and native proteins.
These differences may include posttranslational
modifications occurring in E. coli but not in humans that
may affect the suitability of an antigen generated against
a recombinant bacterial protein as a reagent in
immunological assays (14). No size differences were
observed in SDS-Page between recombinant -pyk-C and
native-pyk-C that cannot be accounted for by the
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presence of a GST tag. More importantly, by using several
different assays with different cell sources, bands
matching in molecular weight with the expected native
pyk-2 were observed. Still, it would be nice to compare
this antibody with the ones generated against short
peptides and recombinant pyk-2 constructs (1, 2) cloned
via different stategies for the sake of better specificity
and sensitivity of detection in physiological samples
possibly using quantitative immunochemical methods.
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